Diannei Technology - About the company
Diannei Technology is a series A company based in Shanghai (China), founded in 2016 by Ge Liang and Jiancheng Yang. It operates as a Developer of AI-based platform for tumor diagnosis and treatment. Diannei Technology has raised an undisclosed amount in funding. The company has 37 active competitors, including 12 funded and 8 that have exited. Its top competitors include companies like Biodesix, OncoCyte and ONCOHOST.
Company Details
Developer of AI-based platform for tumor diagnosis and treatment. The company's platform Fei Anhao is used for early lung cancer screening, benign and malignant identification. The platform combines deep learning with big data of multi-omics including radiology, pathology, proteomics, immunology, and metabonomics.
- Website
- dianei-ai.com
- Email ID
- *****@dianei-ai.com
- Phone Number
- +86 **********
Key Metrics
Founded Year
2016
Location
Shanghai, China
Stage
Series A
Latest Funding Round
Investors
Ranked
23rd among 37 active competitors
Employee Count
1 as on May 31, 2026
Sign up to download Diannei Technology's company profile
Diannei Technology's funding and investors
Diannei Technology has raised funding over 1 round. Its latest funding round was a Series A round on Sep 10, 2021 for $*****. 1 investor participated in its latest round. Diannei Technology has 2 institutional investors.
Here is the list of recent funding rounds of Diannei Technology:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Sep 10, 2021 | 4451909 | Series A | 3951029 | 3443338 | 4110543 | 6576348 |
Access funding benchmarks and valuations. Sign up today!View details of Diannei Technology's funding rounds and investors
Diannei Technology's founders and board of directors
Founder? Claim ProfileThe founders of Diannei Technology are Ge Liang and Jiancheng Yang. Ge Liang is the CEO of Diannei Technology.
Here are the details of Diannei Technology's key team members:
- Ge Liang: Co-Founder & CEO of Diannei Technology.
- Jiancheng Yang: Co-Founder & CTO of Diannei Technology.
View details of Diannei Technology's Founder profiles and Board Members
Diannei Technology's employee count trend
Diannei Technology has 1 employees as of May 26. Here is Diannei Technology's employee count trend over the years:
Uncover Diannei Technology's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Diannei Technology's Competitors and alternates
Top competitors of Diannei Technology include Biodesix, OncoCyte and ONCOHOST. Here is the list of Top 10 competitors of Diannei Technology, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Biodesix 2005, Boulder (United States), Public | Developer of diagnostics assays for the detection of cancer | $200M | 75/100 | |
2nd |  OncoCyte 2009, Irvine (United States), Public | Developer of non-invasive diagnostic tests solutions for the treatment of cancer | $15.3M | 66/100 | |
3rd | AI-based oncology therapy plan solution for professionals | $43M | 60/100 | ||
4th |  Oxford Cancer Analytics 2018, Oxford (United Kingdom), Series A | Provider of a platform for detection of lung cancer | $16.5M | 60/100 | |
5th | Mursla 2017, London (United Kingdom), Seed | Provider of diagnostic device for cancer detection | $547K | 55/100 | |
6th | _1571830790831.png?devicePixelRatio=2&height=30&width=30){kind=logo} Biofidelity 2002, Cambridge (United Kingdom), Series B | Developer of a molecular diagnostic assay for the detection of target DNA sequences | $60M | 50/100 | |
7th |  Inivata 2014, Cambridge (United Kingdom), Acquired | Developer of liquid biopsy platform for detecting cancer | $189M | 50/100 | |
8th | Cizzle Biotechnology 2005, York (United Kingdom), Public | Developer of blood tests for early lung cancer detection | $1.98M | 46/100 | |
9th | _1567753291263.png?devicePixelRatio=2&height=30&width=30){kind=logo} LungLife AI Thousand Oaks (United States), Public | Developer of an AI-enabled biomarker detection tests | $62.3M | 45/100 | |
10th | Hummingbird Diagnostics 2015, Heidelberg (Germany), Seed | Developer of blood tests integrating disease and immune response biomarkers | - | 44/100 | |
23rd |  Diannei Technology 2016, Shanghai (China), Series A | Developer of AI-based platform for tumor diagnosis and treatment | - | 30/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Diannei Technology's competitors? Click here to see the top ones
Diannei Technology's Investments and acquisitions
Diannei Technology has made no investments or acquisitions yet.
News related to Diannei Technology
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Diannei Technology
Explore our recently published companies
- Jazzy Limos - Miami based, Unfunded company
- Rich Kimball Downtown - Bangor based, 2011 founded, Unfunded company
- Jazzy Properties - Rock Hill based, 2009 founded, Unfunded company
- JazzTech Hub - Wheeling based, Unfunded company
- JazzWire Summit - Rockville based, Unfunded company
- Jazz With an Accent - Miami Beach based, Unfunded company
